Evaluation of the Safety and Cardioprotective Effects of Eniporide in Acute Myocardial Infarction - ESCAMI


ESCAMI was a multicenter randomized, double-blinded, placebo-controlled, dose-ranging trial to test the effect of eniporide (an Na+/H+ exchange inhibitor) on infarct size and clinical outcomes in patients treated with either fibrinolytic therapy or primary angioplasty for ST-elevation myocardial infarction (STEMI).